| Literature DB >> 30538504 |
Zhiyao Chen1, Changlin Han1, Xiaobin Huang1, Yangqun Liu1, Dan Guo1, Xiaohua Ye1.
Abstract
BACKGROUND: Methicillin-resistant Staphylococcus aureus (MRSA) causes a wide variety of serious infections worldwide. There are few studies on the prevalence, antimicrobial susceptibility, and molecular characteristics of MRSA contamination in the environment of airports.Entities:
Keywords: Staphylococcus aureus; antimicrobial susceptibility; environment; methicillin-resistant S. aureus; molecular characterization
Year: 2018 PMID: 30538504 PMCID: PMC6251466 DOI: 10.2147/IDR.S178584
Source DB: PubMed Journal: Infect Drug Resist ISSN: 1178-6973 Impact factor: 4.003
Prevalence of S. aureus and MRSA contamination in 1,054 samples collected from different sites
| Characteristics | No. of samples (%) | MRSA
| |||||
|---|---|---|---|---|---|---|---|
| n1 (%) | OR (95% CI) | n2 (%) | OR (95% CI) | ||||
|
| |||||||
| Total | 1,054 (100.0) | 76 (7.2) | 23 (2.2) | ||||
|
| |||||||
|
| |||||||
| Escalators | 233 (22.1) | 8 (3.4) | 1.00 (reference) | 2 (0.9) | 1.00 (reference) | ||
| Luggage trolleys | 251 (23.8) | 11 (4.4) | 1.29 (0.51–3.26) | 0.592 | 0 (0.0) | 1.00 (reference) | |
| Self-service machines | 244 (23.1) | 34 (13.9) | 4.55 (2.06–10.06) | <0.001 | 12 (4.9) | 12.47 (2.77–56.15) | 0.001 |
| Luggage detectors | 68 (6.5) | 8 (11.8) | 3.75 (1.35–10.40) | 0.011 | 3 (4.4) | 11.12 (1.82–67.82) | <0.001 |
| Seat handles | 219 (20.8) | 13 (5.9) | 1.77 (0.72–4.37) | 0.212 | 5 (2.3) | 5.63 (1.08–29.25) | 0.040 |
| Water dispensers | 39 (3.7) | 2 (5.1) | 1.52 (0.31–7.44) | 0.605 | 1 (2.5) | 6.34 (0.56–71.54) | 0.135 |
Notes:
Both escalators and luggage trolleys were used as the reference group. n1, frequency of S. aureus-positive samples; n2, frequency of MRSA-positive samples.
Abbreviations: MRSA, methicillin-resistant S. aureus; S. aureus, Staphylococcus aureus.
Phenotypic and molecular characteristics of MSSA and MRSA isolates
| Characteristics | OR (95% CI) | ||||
|---|---|---|---|---|---|
| Total (n=89) | MSSA (n=61) | MRSA (n=28) | |||
|
| |||||
|
| |||||
| Clindamycin | 30 (33.7) | 21 (34.4) | 9 (32.1) | 0.90 (0.30–2.55) | 0.999 |
| Tetracycline | 20 (22.5) | 6 (9.8) | 14 (50.0) | 8.88 (2.65–33.73) | <0.001 |
| Erythromycin | 32 (36.0) | 20 (32.8) | 12 (42.9) | 1.53 (0.55–4.23) | 0.476 |
| Trimethoprim–sulfamethoxazole | 21 (23.6) | 12 (19.7) | 9 (32.1) | 1.92 (0.61–5.94) | 0.282 |
| Gentamicin | 3 (3.4) | 2 (3.3) | 1 (3.6) | 1.09 (0.02–21.82) | 0.999 |
| Chloramphenicol | 11 (12.4) | 6 (9.8) | 5 (17.9) | 1.98 (0.43–8.67) | 0.312 |
| Rifampin | 20 (22.5) | 13 (21.3) | 7 (25.0) | 1.23 (0.36–3.91) | 0.786 |
| Ciprofloxacin | 26 (29.2) | 15 (24.6) | 11 (39.3) | 1.97 (0.68–5.70) | 0.210 |
| Quinupristin–dalfopristin | 22 (24.7) | 14 (23.0) | 8 (28.6) | 1.34 (0.42–4.09) | 0.603 |
| Linezolid | 6 (6.7) | 4 (6.6) | 2 (7.1) | 0.40 (0.0–3.29) | 0.304 |
| MDR | 56 (62.9) | 28 (45.9) | 28 (100.0) | 44.48 (7.31–∞) | <0.001 |
|
| |||||
|
| |||||
| 11 (12.4) | 8 (13.0) | 3 (10.7) | 0.80 (0.13–3.69) | 0.999 | |
| 47 (52.8) | 30 (49.2) | 17 (60.7) | 1.59 (0.59–4.43) | 0.365 | |
| 15 (16.9) | 12 (19.7) | 3 (10.7) | 0.49 (0.08–2.07) | 0.372 | |
| 73 (82.0) | 50 (82.0) | 23 (82.1) | 1.01 (0.28–4.16) | 0.999 | |
| 8 (9.0) | 5 (8.2) | 3 (10.7) | 1.34 (0.19–7.52) | 0.999 | |
|
| |||||
|
| |||||
| 7 (7.9) | 5 (8.2) | 2 (7.1) | 0.86 (0.08–5.71) | 0.999 | |
| 3 (3.4) | 0 (0.0) | 3 (10.7) | 8.93 (1.01–∞) | 0.029 | |
| 10 (11.4) | 8 (13.3) | 2 (7.1) | 0.51 (0.05–2.83) | 0.495 | |
| 2 (2.3) | 2 (3.3) | 0 (0.0) | 0.89 (0.0–11.67) | 0.564 | |
| 20 (22.5) | 14 (23.0) | 6 (21.4) | 0.92 (0.25–2.98) | 0.999 | |
| 14 (15.7) | 9 (14.8) | 5 (17.9) | 1.25 (0.30–4.73) | 0.758 | |
| 1 (1.1) | 0 (0.0) | 1 (3.6) | 2.18 (0.06–∞) | 0.315 | |
| 1 (1.1) | 1 (1.6) | 0 (0.0) | 2.18 (0.0–84.96) | 0.999 | |
|
| |||||
|
| |||||
| 60 (67.4) | 43 (70.5) | 17 (60.7) | 0.65 (0.23–1.86) | 0.466 | |
| 52 (58.4) | 32 (52.5) | 20 (71.4) | 2.25 (0.80–6.85) | 0.109 | |
| 60 (67.4) | 43 (70.5) | 17 (60.7) | 0.65 (0.23–1.86) | 0.466 | |
| 6 (6.7) | 6 (9.8) | 0 (0.0) | 0.25 (0.0–1.81) | 0.171 | |
| Exfoliative toxin genes | 0 (0.0) | 0 (0.0) | 0 (0.0) | – | – |
| 0 (0.0) | 0 (0.0) | 0 (0.0) | – | – | |
Notes: Values are expressed as the number of isolates with characteristics (the proportion of isolates with characteristics), except where specified otherwise.
ORs were estimated by the exact logistic regression.
All isolates were negative for some enterotoxin genes, including sea, sec, sed, see, seh, sel, sen, seq, ser, and seu.
All isolates were negative for all exfoliative toxin genes, including eta, etb, and etd.
No estimate was provided due to the lack of occurrence of the outcome of interest in the two groups.
Abbreviations: IEC, immune evasion cluster; MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-sensitive Staphylococcus aureus.
Figure 1Correspondence analysis for the relationship between CC and resistance pattern (A), the number of IEC genes (B), the number of enterotoxin genes (C), or the number of hemolysin genes (D) of S. aureus isolates.
Abbreviations: CC, clonal complex; IEC, immune evasion cluster; MDR, multidrug resistant; S. aureus, Staphylococcus aureus.
Relationship between predominant CCs and phenotype–genotype characteristics of S. aureus isolates
| Variables | CC5 | CC6 | CC7 | CC8 | CC20 | CC30 | CC45 | CC59 | CC188 | ST288 | CC398 | CC672 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| ||||||||||||
| Total | 6 | 9 | 5 | 4 | 6 | 7 | 4 | 9 | 9 | 5 | 6 | 4 |
|
| ||||||||||||
|
| ||||||||||||
| Penicillin | 5 | 6 | 4 | 4 | 6 | 7 | 4 | 8 | 9 | 4 | 6 | 4 |
| Clindamycin | 5 | 2 | 0 | 1 | 4 | 5 | 2 | 7 | 4 | 4 | 1 | 0 |
| Tetracycline | 2 | 1 | 1 | 0 | 2 | 0 | 0 | 6 | 3 | 0 | 0 | 2 |
| Erythromycin | 4 | 3 | 0 | 1 | 4 | 7 | 1 | 7 | 3 | 4 | 1 | 1 |
| SXT | 2 | 2 | 1 | 1 | 0 | 0 | 0 | 4 | 1 | 3 | 3 | 4 |
| Gentamicin | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 |
| Chloramphenicol | 2 | 0 | 1 | 0 | 0 | 0 | 0 | 2 | 1 | 1 | 1 | 1 |
| Cefoxitin | 3 | 1 | 0 | 0 | 1 | 0 | 1 | 6 | 1 | 1 | 1 | 0 |
| Rifampicin | 1 | 2 | 1 | 0 | 3 | 2 | 4 | 2 | 1 | 1 | 4 | 0 |
| Ciprofloxacin | 0 | 4 | 2 | 1 | 5 | 0 | 0 | 3 | 2 | 4 | 1 | 4 |
| QD | 2 | 4 | 1 | 1 | 3 | 5 | 0 | 4 | 3 | 1 | 3 | 0 |
| Linezolid | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 |
|
| ||||||||||||
|
| ||||||||||||
| 0 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 3 | 0 | 2 | 1 | |
| 3 | 4 | 2 | 2 | 4 | 1 | 4 | 8 | 7 | 1 | 4 | 2 | |
| 6 | 8 | 3 | 1 | 5 | 7 | 4 | 9 | 9 | 2 | 6 | 4 | |
| 0 | 6 | 0 | 0 | 0 | 7 | 0 | 2 | 0 | 0 | 0 | 0 | |
| 1 | 0 | 3 | 1 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 1 | |
|
| ||||||||||||
|
| ||||||||||||
| 0 | 1 | 0 | 0 | 0 | 0 | 0 | 2 | 3 | 0 | 0 | 0 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | |
| 1 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 1 | 0 | 0 | 3 | |
| 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | |
| 2 | 0 | 0 | 0 | 5 | 2 | 4 | 0 | 1 | 0 | 0 | 4 | |
| 1 | 0 | 0 | 0 | 4 | 0 | 3 | 0 | 1 | 0 | 0 | 3 | |
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
|
| ||||||||||||
|
| ||||||||||||
| 3 | 6 | 3 | 4 | 6 | 5 | 4 | 8 | 8 | 0 | 4 | 4 | |
| 5 | 5 | 2 | 3 | 4 | 1 | 1 | 9 | 8 | 2 | 2 | 3 | |
| 3 | 6 | 3 | 4 | 5 | 5 | 4 | 8 | 8 | 0 | 5 | 4 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Notes: Values are expressed as the number of isolates. All isolates were negative for pvl and some enterotoxin genes (sea, sec, sed, see, seh, sel, sen, seq, ser, and seu).
Abbreviations: CC, clonal complex; IEC, immune evasion cluster; QD, quinupristin–dalfopristin; S. aureus, Staphylococcus aureus; SXT, trimethoprim–sulfamethoxazole.
Figure 2Clonal dendrogram and detailed molecular characteristics of 28 MRSA isolates.
Abbreviations: CC, clonal complex; IEC, immune evasion cluster; MRSA, methicillin-resistant Staphylococcus aureus; ST, sequence type; NT, non-typeable.
Figure 3Clonal dendrogram and detailed molecular characteristics of 61 MSSA isolates.
Abbreviations: CC, clonal complex; IEC, immune evasion cluster; MSSA, methicillin-sensitive Staphylococcus aureus; ST, sequence type.